The Various Effects of Gaseous Albuterol on Serum Lactate

• Status: Completed
• Trial end date: 2015-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Empirical data from physician observation indicates an increase in serum lactate in acute asthmatic patients being treated with inhaled albuterol therapy.

It is not clear if this increased serum lactate is in response to a physiological response to the asthmatic process or from the albuterol treatment.

This study is designed to determine if administration of inhaled albuterol increases serum lactate in healthy subjects.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University Medical Center of Southern Nevada
• Treatments: Albuterol

Criteria

Inclusion Criteria:

• 18 years or older

Exclusion Criteria:

• Pregnant

• Prisoner

• beta agonist allergy

• hypokalemia

• taking furosemide, insulin, thiazide diuretics, metformin or acetazolamide

• coronary artery disease

• hyperthyroidism

• abnormal heart rhythm

• baseline serum lactate level >2.2 mmol/L

• baseline heart rate > 120